Emanuel F Petricoin1, Lance A Liotta
1U. S. Food and Drug Administration-National Cancer Institute Clinical Proteomics Program, Center for Biologic Evaluation and Research, U. S. Food and Drug Administration, Rockville, MD 20852, USA. petricoin@cber.fda.gov
Proteomics involves more than protein expression changes; it deciphers cellular information flow for disease insights. This systematic protein analysis aids in early cancer detection and personalized therapies.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: